1694
I. Meyer-Wilmes et al. / Tetrahedron 65 (2009) 1689–1696
diluted with pentane (75 mL), hydrolyzed with saturated ammo-
nium chloride (50 mL), and the organic phase was washed with
water (2ꢁ50 mL) and dried (MgSO4). The solvents were distilled off
(bath temperature 50 ꢂC/15 Torr), and the residue (3.86 g yellow
oil) was chromatographed on silica gel (0.05–0.20 mm) in pentane/
ether (95:5, column 70ꢁ4.5 cm, control by GC) to yield 1.14 g (76%)
of a 1:1 mixture of 17 and 22 as colorless solid, mp 34–36 ꢂC. The
data refer to the mixture. 1H NMR (600 MHz, C6D6, C6D5H int):
2C), 52.75 (s, 2C), 52.92 (t, 2C), 85.66 (d); MS (EI): m/z¼302 (22,
Mþ), 284 (21, MþꢃH2O), 67 (100); HRMS m/z (Mþ) calcd 302.2620,
obsd 302.2610. Compound 26: 1H NMR (600 MHz, C6D6, C6D5H int):
d
¼1.14 (br s, 1H), 1.21 (d, J¼13 Hz, 1H), 1.26 (ddd, J¼12, 6, 6 Hz, 1H),
1.43 (d, J¼13 Hz, 1H), 1.46–1.58 (m, 14H), 1.58–1.73 (m, 13H), 1.97
(ddd, J¼12, 8, 8 Hz, 1H), 2.04 (d, J¼13 Hz, 1H), 3.34 (s, 1H); 13C NMR
(150.8 MHz, C6D6, C6D6 int):
d¼24.52 (t), 24.60 (t), 24.90 (t), 24.93
(t), 33.58 (t), 38.37 (t), 38.40 (t), 38.96 (t), 39.45 (t), 39.73 (t), 40.59
(t), 40.62 (t), 40.66 (t), 40.97 (t), 46.36 (t), 50.19 (s), 50.87 (s), 52.87
(t), 52.96 (s), 53.27 (s), 85.94 (d); MS (EI): m/z¼302 (23, Mþ), 284
(15, MþꢃH2O), 67 (100); HRMS m/z (Mþ) calcd 302.2620, obsd
302.2610.
d
¼1.265 (d, J¼12.5 Hz, 1H), 1.275 (d, J¼13 Hz, 1H), 1.33–1.70 (m,
26H), 1.90 (ddd, J¼12.5, 7.5, 7.5 Hz, 1H), 1.96 (d, J¼13 Hz, 1H), 2.00
(ddd, J¼13, 7.5, 7.5 Hz, 1H), 2.05 (d, J¼12.5 Hz, 1H); 13C NMR
(150.8 MHz, C6D6, C6D6 int):
d¼24.67 (t), 24.71 (t), 24.96 (t), 24.97
(t), 37.09 (t), 37.14 (t), 37.66 (t), 37.82 (t), 39.33 (t), 39.36 (t), 39.44
(t), 39.60 (t), 39.90 (t), 39.90 (t), 50.17 (t), 50.42 (t), 51.80 (s), 51.84
(s), 55.57 (s), 55.60 (s), 225.33 (s), 225.49 (s). C21H32O requires: C,
83.94; H, 10.73. Found: C, 84.11; H, 10.66.
3.15. rel-(7R,9R)-Tetraspiro[4.1.1.1.4.2.2.2]heneicosan-8-one
[rel-(7R,9R)-17]
To pyridinium chlorochromate (173 mg, 0.80 mmol) was added
under argon with stirring a solution of 26 (121 mg, 0.40 mmol) in
dichloromethane (2.0 mL). After 1 h at room temperature, the re-
action was complete according to GC [column A, 230 ꢂC; retention
times (min): 5.33 (26), 5.88 (17)]. The mixture was diluted with
ether (5 mL), the liquid phase was decanted, the residual black tar
was extracted with ether (2ꢁ2 mL), and the combined organic
phases were first filtrated over a short pad of silica gel (0.05–
0.20 mm; column 7ꢁ2 cm) and then concentrated (bath tempera-
ture 60 ꢂC/15 Torr) to yield 117 mg (97%) of 17 as colorless solid, mp
56–58 ꢂC (purity >99%, GC). IR (KBr): 1720 cmꢃ1 (C]O); 1H NMR
3.13. ( )-Tetraspiro[4.1.1.1.4.2.2.2]heneicosane [( )-10] and
meso-tetraspiro[4.1.1.1.4.2.2.2]heneicosane (meso-23)
The 1:1 mixture of 17 and 22 (140 mg, 0.50 mmol) was reduced
as described for 16 (see Section 3.7). According to GC [column A,
230 ꢂC; retention times (min): 2.60 (10/23), 5.89 (17/22), 7.72
(hydrazones)], after 24 h at 140 ꢂC the mixture contained >90%
hydrazones, and after additional 48 h at 200 ꢂC >90% 10 and 23.
Work up and chromatography yielded 93 mg (65%) of a 1:1 mixture
of 10 and 23 as colorless liquid (purity 95% GC). The data refer to the
mixture. 1H NMR (600 MHz, CDCl3, CHCl3 int):
12H), 1.52–1.60 (m, 22H); 13C NMR (150.8 MHz, CDCl3, CDCl3 int):
d¼1.40–1.48 (m,
(600 MHz, C6D6, C6D5H int):
(m, 26H), 1.90 (ddd, J¼12.5, 7.5, 7.5 Hz, 2H), 2.06 (d, J¼12.5 Hz, 2H);
13C NMR (150.8 MHz, C6D6, C6D6 int):
d
¼1.27 (d, J¼12.5 Hz, 2H), 1.33–1.69
d
¼24.23 (t) (coincidence of two lines), 24.29 (t) (coincidence of two
d¼24.70 (t, 2C), 24.97 (t, 2C),
lines), 39.12 (t), 39.18 (t), 40.86 (t), 40.88 (t) (coincidence of two
lines), 40.89 (t), 40.90 (t), 40.91 (t), 41.12 (t), 41.14 (t), 50.29 (s)
(coincidence of two lines), 50.31 (s), 50.32 (s), 54.46 (t), 54.49 (t),
55.95 (t), 56.05 (t).
37.13 (t, 2C), 37.83 (t, 2C), 39.34 (t, 2C), 39.44 (t, 2C), 39.90 (t, 2C),
50.18 (t, 2C), 51.80 (s, 2C), 55.59 (s, 2C), 225.41 (s); MS (EI): m/z¼300
(23, Mþ), 205 (100); HRMS m/z (Mþ) calcd 300.2453, obsd
300.2453.
3.14. rel-(7R,8R,9S)-Tetraspiro[4.1.1.1.4.2.2.2]heneicosane-8-ol
[rel-(7R,8R,9S)-24], rel-(7R,8S,9S)-tetraspiro[4.1.1.1.4.2.2.2]-
heneicosane-8-ol [rel-(7R,8S,9S)-25], and rel-(7R,9R)-
tetraspiro[4.1.1.1.4.2.2.2]heneicosane-8-ol [rel-(7R,9R)-26]
3.16. rel-(7R,9S)-Tetraspiro[4.1.1.1.4.2.2.2]heneicosan-8-one
[rel-(7R,9S)-22]
3.16.1. From 24
Compound 24 (75 mg, 0.25 mmol) was oxidized as described for
26 (see Section 3.15) yielding 67 mg (89%) of 22 as colorless solid,
mp 50–52 ꢂC (purity >98%, GC) [column A, 230 ꢂC, retention times
(min): 5.11 (24), 5.89 (22)]. IR (KBr): 1720 cmꢃ1 (C]O); 1H NMR
To
a suspension of lithium aluminum hydride (285 mg,
7.5 mmol) in ether (30 mL) was added under argon with stirring
a solution of a 1:1 mixture of 17 and 22 (450 mg, 1.5 mmol) in ether
(5 mL). After 1 h of reflux, the reaction was complete according to
GC [column A, 230 ꢂC; retention times (min): 5.45 (24/25/26), 5.89
(17/22)]. The mixture was treated with water (300
KOH (300 L), and water (900 L), the organic phase was decanted,
and the residue was extracted with ether (3ꢁ20 mL). The combined
organic phases were concentrated (bath temperature 60 ꢂC/
15 Torr) and the solid residue (438 mg) was chromatographed on
silica gel (0.040–0.063 mm) in pentane/ether [97:3, column
100ꢁ2.5 cm, Rf¼0.18 (24), 0.15 (26), 0.13 (25)] to yield 78 mg (17%)
24, mp 92–94 ꢂC, 89 mg (20%) 25, mp 170–172 ꢂC, and 147 mg (32%)
26, mp 82–84 ꢂC, as colorless solids. Compound 24: 1H NMR
(600 MHz, C6D6, C6D5H int):
1.46–1.56 (m,14H),1.56–1.72 (m,14H), 2.06 (d, J¼13 Hz, 2H), 3.32 (s,
1H); 13C NMR (150.8 MHz, C6D6, C6D6 int):
(600 MHz, C6D6, C6D5H int):
d
¼1.27 (d, J¼13 Hz, 2H), 1.34–1.70 (m,
26H), 1.96 (d, J¼13 Hz, 2H), 2.01 (ddd, J¼13, 7.5, 7.5 Hz, 2H); 13C
mL), 15% aqueous
NMR (150.8 MHz, C6D6, C6D6 int):
d
¼24.67 (t, 2C), 24.96 (t, 2C),
m
m
37.08 (t, 2C), 37.67 (t, 2C), 39.36 (t, 2C), 39.60 (t, 2C), 39.91 (t, 2C),
50.43 (t, 2C), 51.84 (s, 2C), 55.61 (s, 2C), 225.55 (s); MS (EI):
m/z¼300 (27, Mþ), 205 (100); HRMS m/z (Mþ) calcd 300.2453, obsd
300.2453.
3.16.2. From 25
Compound 25 (75 mg, 0.25 mmol) was oxidized as described for
26 (see Section 3.15) yielding 70 mg (93%) of 22 as colorless solid,
mp 50–52 ꢂC (purity >98%, GC) [column A, 230 ꢂC; retention times
(min): 5.63 (25), 5.89 (22)]. The 1H and 13NMR data were identical
with those of authentic material.
d¼1.07 (br s, 1H), 1.23 (d, J¼13 Hz, 2H),
d¼24.53 (t, 2C), 24.90 (t,
2C), 38.42 (t, 2C), 39.06 (t, 2C), 39.70 (t, 2C), 40.60 (t, 2C), 40.95 (t,
2C), 46.43 (t, 2C), 50.79 (s, 2C), 53.43 (s, 2C), 86.15 (d); MS (EI):
m/z¼302 (11, Mþ), 284 (10, MþꢃH2O), 67 (100); HRMS m/z (Mþ)
calcd 302.2620, obsd 302.2610. Compound 25: 1H NMR (600 MHz,
3.17. ( )-Tetraspiro[4.1.1.1.4.2.2.2]heneicosane [( )-10]
Compound 17 (90 mg, 0.30 mmol) was reduced as described for
16 (see Section 3.7) and the mixture of 10 and 23 (see Section 3.13)
yielding 43 mg (52%) of (ꢀ)-10 as colorless liquid (purity >98% GC)
[column A, 230 ꢂC; retention times (min): 2.41 (10), 5.45 (17), 7.17
C6D6, C6D5H int):
d¼1.03 (br s, 1H), 1.23 (ddd, J¼12, 6, 6 Hz, 2H), 1.41
(d, J¼13 Hz, 2H), 1.45–1.54 (m, 14H), 1.57–1.64 (m, 10H), 1.66 (d,
J¼13 Hz, 2H), 1.96 (ddd, J¼12, 8, 8 Hz, 2H), 3.33 (br s, 1H); 13C NMR
(150.8 MHz, C6D6, C6D6 int):
d¼24.61 (t, 2C), 24.94 (t, 2C), 33.46 (t,
(hydrazone)]. 1H NMR (600 MHz, CDCl3, CHCl3 int):
d
¼1.40–1.48
2C), 38.45 (t, 2C), 39.54 (t, 2C), 40.53 (t, 2C), 40.60 (t, 2C), 50.09 (s,
(m, 12H), 1.50–1.57 (m, 22H); 13C NMR (150.8 MHz, CDCl3, CDCl3